Growth and Funding AOTI's successful IPO on London's AIM market and recent closures of significant funding rounds demonstrate strong investor confidence and financial stability, indicating resources available for scaling sales efforts and expanding market presence.

Innovative Product Line The company's launch of multi-modality Topical Wound Oxygen therapy and expansion of its wound care product portfolio position it as a leader in advanced wound management solutions, creating cross-selling opportunities with healthcare providers treating chronic wounds.

Global Expansion With a manufacturing facility in Galway, Ireland, and a growing footprint in international markets, AOTI is well-positioned to serve global healthcare providers, opening avenues for international sales collaborations and market penetration.

Market Focus AOTI's emphasis on non-invasive oxygen wound healing solutions aligns with increasing demand for minimally invasive therapies, offering potential for expansion within hospital networks, wound care clinics, and home health companies seeking advanced treatment options.

Strategic Leadership The appointment of experienced commercial leadership and recent product launches suggest a proactive growth strategy, making the company a compelling partner for distribution and sales channels looking to add innovative wound care technologies.